Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (NCT07890480) titled 'Aztreonam-Avibactam in Immunocompromised Hosts' on Oct. 16.
Study Type: Observational
Primary Sponsor: Centro de Educación Medica e Investigaciones Clinicas Norberto Quirno
Condition:
Enterobacteriaceae Infections
Carbapenem-Resistant Enterobacteriaceae Infection
Immunocompromised Host
Drug Resistance, Multiple, Bacterial
Intervention:
Drug: Aztreonam-Avibactam
Recruitment Status: Recruiting
Date of First Enrollment: October 14, 2026
Target Sample Size: 814
Countries of Recruitment:
Argentina
To know more, visit https://clinicaltrials.gov/study/NCT07890480
Disclaimer: Curated by HT Syndication....